Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy [Phase 2, Phase 3]
Phase 2/3 trial comparing N-acetyl-L-cysteine (NAC) to supportive therapy for prolonged isolated thrombocytopenia after allogeneic stem cell…
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP [Phase 2]
Phase 2 randomized open-label study comparing oseltamivir plus high-dose dexamethasone (HD-DEX) versus HD-DEX alone for thrombocytopenia man…
-
CLINICAL_TRIALS trial_result · 2020-05-06Clinical Trial Update: Prospective Study of Patients With Thrombocytopenia Following HSCT [Phase 3]
Phase 3 clinical trial update for thrombocytopenia after hematopoietic stem cell transplantation has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-04-15Clinical Trial Update: Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure [Phase 3]
Phase 3 trial of avatrombopag for thrombocytopenia in adults undergoing procedures was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-20Clinical Trial Update: Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP) [Phase 1, Phase 2]
Clinical trial update for AMG 531 (Megakaryopoiesis Protein 2) in thrombocytopenic subjects with immune thrombocytopenic purpura (ITP) compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Study of Quadruple Therapy With Eltrombopag for Chronic Hepatitis C [Phase 2, Phase 3]
A Phase 2/3 trial evaluating quadruple therapy with eltrombopag for thrombocytopenia in chronic hepatitis C was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia [Phase 2]
Phase 2 clinical trial assessing management of platelet transfusion therapy in patients with blood cancers or treatment-induced thrombocytop…
-
CLINICAL_TRIALS research · 2019-08-28Clinical Trial Update: Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. [Phase 3]
Phase 3 clinical trial assessing hematologic and immunological profiles in immune thrombocytopenic purpura (ITP) exploring evolution of the …
-
CLINICAL_TRIALS trial_result · 2019-08-22Clinical Trial Update: A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 pilot study evaluating eltrombopag, a thrombopoietin-receptor agonist, in patients with low- to intermediate-2 risk myelodysplastic …
-
CLINICAL_TRIALS trial_result · 2019-07-30Clinical Trial Update: Eltrombopag for Post Transplant Thrombocytopenia [Phase 2]
Phase 2 clinical trial of eltrombopag for post-transplant thrombocytopenia has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Study of Sirolimus in CTD-TP in China [Phase 4]
A Phase 4 clinical trial update for sirolimus in CTD-TP in China is reported, with unclear status for the study.
-
CLINICAL_TRIALS trial_result · 2019-03-18Clinical Trial Update: Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients [Phase 2]
Phase 2 clinical trial update addressing thrombocytopenia and bleeding in patients with Wiskott-Aldrich Syndrome; study terminated with post…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia [Phase 2]
A Phase 2 clinical trial update comparing Interleukin-11 and rhTPO for patients with recurrent colorectal cancer and thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Patients With Immune (Idiopathic) Thrombocytopenia Purpura [Phase 3]
Phase 3 trial evaluating long-term dosing safety and efficacy of romiplostim in pediatric patients with immune thrombocytopenia purpura (ITP…
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia [Phase 2]
Phase 2 trial investigating eculizumab, a complement inhibitor, to overcome platelet transfusion refractoriness in patients with severe thro…
-
CLINICAL_TRIALS trial_result · 2018-11-30Clinical Trial Update: Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) [Phase 3]
A Phase 3 clinical trial evaluating Angiomax (bivalirudin) in patients with HIT/HITTS type II undergoing off-pump coronary artery bypass gra…
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: High-dose Use of rhTPO in CIT Patients [Phase 4]
A phase 4 clinical trial update evaluating high-dose rhTPO in CIT patients with thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML [Phase 2, Phase 3]
Phase 2/Phase 3 trial updates explore eltrombopag for thrombocytopenia after consolidation therapy in acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2018-09-25Clinical Trial Update: Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures [Phase 3]
Phase 3 trial assessing safety and efficacy of lusutrombopag for thrombocytopenia in patients with chronic liver disease undergoing invasive…
-
FDA approval · 2018-07-31FDA Approved: MULPLETA — Original Application (Eddingpharm (U. S. ) Inc.)
The FDA granted original approval for Mulpleta (lusutrombopag) for adults with chronic liver disease to raise platelet counts in advance of …
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients [Phase 2]
Phase 2 pilot study of eltrombopag in refractory aplastic anemia completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Thrombocytopenia Induced by Chemotherapy [NA]
A completed clinical trial studying chemotherapy-induced thrombocytopenia has been updated. The study is sponsored by Socrates School Of Hea…
-
FDA approval · 2018-05-21FDA Approved: DOPTELET — Original Application (AkaRx, Inc.)
FDA approved DOPTELET (avatrombopag) from AkaRx, Inc. for reducing the need for platelet transfusions in adults with chronic liver disease u…
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Romiplostim in Thoracic Transplantation
A completed clinical trial evaluating romiplostim for thrombocytopenia in thoracic transplantation. Sponsor: Nantes University Hospital.
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Prevention of Thrombocytopenia in Glioblastoma Patients [Phase 2]
A Phase 2 clinical trial assessing strategies to prevent thrombocytopenia in glioblastoma patients has been terminated.